This compound is primarily utilized in biomedical research as a selective inhibitor of glycogen synthase kinase-3 beta (GSK-3β). It is extensively studied for its potential therapeutic applications in neurodegenerative diseases, such as Alzheimer's disease, due to its role in modulating tau protein phosphorylation. Additionally, it is investigated in cancer research for its ability to regulate cell proliferation and apoptosis. The compound is also explored in diabetes research, as GSK-3β is involved in insulin signaling pathways. Its dual E/Z isomeric form allows for a broader understanding of structure-activity relationships in drug development.